|1.||Xie, Yan-Ming: 8 articles (09/2014 - 09/2012)|
|2.||Jiang, Jun-Jie: 4 articles (09/2014 - 09/2013)|
|3.||Zhuang, Yan: 3 articles (09/2014 - 09/2013)|
|4.||Yang, Hu: 3 articles (09/2014 - 09/2013)|
|5.||Liao, Xing: 3 articles (09/2014 - 09/2012)|
|6.||Zhang, Hui: 2 articles (09/2014 - 09/2013)|
|7.||Li, Yuan-Yuan: 1 article (09/2014)|
|8.||Cheng, Hao: 1 article (09/2014)|
|9.||Xiang, Yong-Yang: 1 article (09/2013)|
|10.||Shen, Hao: 1 article (09/2013)|
09/01/2012 - "Conclusions from this review may have a high risk of bias because of the low quality of the researches, hence it was not adequate to draw any reliable conclusions about the efficacy of Shuxuetong injection in progressive ischaemic stroke. "
09/01/2012 - "Randomized controlled trials (RCTs) and quasi randomized controlled trials (quasi-RCTs), which focused on treating patients with progressive ischaemic stroke using Shuxuetong injection were identified from Cochrane library, Medline, EMbase, CBM database, CNKI database, VIP database and Wanfang database. "
09/01/2012 - "To assess the clinical efficacy and safety of Shuxuetong injection against progressive ischaemic stroke. "
09/01/2012 - "[Systematic review of Shuxuetong injection for progressive ischaemic stroke]."
05/01/2010 - "The 160 patients with acute ischemic stroke were divided into two groups randomly: treatment group 85 cases (Songling Xuemaikang + Shuxuetong + Aspirin enterie coated tablets), control group 75 cases (Shuxuetong + Aspirin enterie ccoated tablets). "
09/01/2013 - "Therefore, based on existing data, for the treatment of cerebral infarction, the outcomes are more effective when combination therapy including Shuxuetong is used."
09/01/2013 - "[Based on propensity score methods analysis of outcomes of parenterally administered shuxuetong in treatment of cerebral infarction]."
09/01/2013 - "Patients with cerebral infarction crowd using parenterally administered Shuxuetong were a mostly elderly population, with an average age of 66. "
09/01/2013 - "Patients receiving parenterally administered Shuxuetong for the treatment of cerebral infarction were included. "
09/01/2012 - "[Reasonable and safe application of Shuxuetong injection and intravenous medication's combined application in acute cerebral infarction's therapy]."
|3.||Venous Thrombosis (Deep-Vein Thrombosis)
10/01/2011 - "To evaluate the efficacy of Tuina and Chinese patent drug Shuxuetong injection in preventing patients undergoing total knee arthroplasty from deep venous thrombosis and in functional rehabilitation. "
10/01/2011 - "[Effects of Tuina and Chinese patent drug Shuxuetong injection on deep venous thrombosis and functional rehabilitation after total knee arthroplasty]."
10/01/2011 - "Tuina combined with Shuxuetong injection treatment can prevent deep venous thrombosis in patients with rheumatoid arthritis after total knee arthroplasty."
|4.||Drug Toxicity (Drug Safety)
09/01/2014 - "Accoeding to levels of evidence from high to low, the evidence related to the safety of Shuxuetong injection was classified as following: the evidence from a long-term, prospective, large-sample-size and intensive hospital monitoring study was the strongest; the evidence of hospital information system (HIS) data analysis; the evidence of spontaneous reporting system (SRS) data analysis; the evidence of adverse drugreactions (ADRs)/adverse drug events (ADEs) reported in systematic evaluation, ADRs case report, toxicological tests, pharmacological tests were weakest. "
09/01/2013 - "In this study, January 2009-December 2012 national adverse drug reaction monitoring center Shuxuetong the SRS data for the study, using the reporting rate ratio method and Bayesian belief propagation neural network Shuxuetong ADR warning signal, and balanced use of propensity score methods confounders. "
09/01/2012 - "To evaluate the clinical adverse drug reactions (ADR) of Shuxuetong Injection (SXTI) comprehensively for its proper use and post-marketing reevaluation. "
01/01/2006 - "Objective To study the protective effect and mechanism of Shuxuetong on gerbil brain tissue from the area of ischemia-reperfusion. "
01/01/2006 - "Conclusion Shuxuetong has protective effect on brain tissue of ischemia-reperfusion by enhancing the expression of GABA in the hippocampal tissue."
|1.||Aspirin (Acetylsalicylic Acid)
|2.||Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
|3.||Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
|7.||Phosphopyruvate Hydratase (Enolase)
|10.||Isosorbide Dinitrate (Isordil)
|2.||Chinese Traditional Medicine (Traditional Chinese Medicine)
|4.||Activities of Daily Living (ADL)